IDEAS home Printed from https://ideas.repec.org/p/osf/socarx/z5mf6.html
   My bibliography  Save this paper

Power, Disputes, and Geopolitics in the Pharmaceutical Sector

Author

Listed:
  • Stacciarini, João Henrique Santana

    (Federal University of Goiás)

Abstract

The pharmaceutical sector achieved global revenues of USD 1.6 trillion in 2023, underscoring its immense economic power and strategic influence on the modern economy and global politics. This article, grounded in extensive data collection, systematization, and analysis, explores the dynamics of this power and influence. It examines the economic and political value of companies in the sector, the conflicts between corporations and nations, the geopolitical role of the sector during the COVID-19 pandemic, and its capacity to shape domestic policies through intensive lobbying, financial contributions to lawmakers, and interactions with regulatory and oversight bodies.

Suggested Citation

  • Stacciarini, João Henrique Santana, 2024. "Power, Disputes, and Geopolitics in the Pharmaceutical Sector," SocArXiv z5mf6, Center for Open Science.
    • Handle: RePEc:osf:socarx:z5mf6
    DOI: 10.31219/osf.io/z5mf6
    as

    Download full text from publisher

    File URL: https://osf.io/download/67785b2fbcf73b5107828fc7/
    Download Restriction: no
    File URL: https://libkey.io/10.31219/osf.io/z5mf6?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Salamon, Lester M. & Siegfried, John J., 1977. "Economic Power and Political Influence: The Impact of Industry Structure on Public Policy," American Political Science Review, Cambridge University Press, vol. 71(3), pages 1026-1043, September.
    2. Priya Gauttam & Bawa Singh & Jaspal Kaur, 2020. "COVID-19 and Chinese Global Health Diplomacy: Geopolitical Opportunity for China’s Hegemony?," Millennial Asia, , vol. 11(3), pages 318-340, December.
    3. Darius N. Lakdawalla, 2018. "Economics of the Pharmaceutical Industry," Journal of Economic Literature, American Economic Association, vol. 56(2), pages 397-449, June.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. repec:osf:socarx:z5mf6_v1 is not listed on IDEAS
    2. repec:osf:socarx:z5mf6_v2 is not listed on IDEAS
    3. Yan Yi & Huimin Liu & Yifan Yang, 2024. "Media debates about China’s role as a global public goods supplier: frame contestation in reporting on the Chinese COVID-19 vaccine," Palgrave Communications, Palgrave Macmillan, vol. 11(1), pages 1-13, December.
    4. Francis,David C. & Kubinec ,Robert, 2022. "Beyond Political Connections : A Measurement Model Approach to Estimating Firm-levelPolitical Influence in 41 Economies," Policy Research Working Paper Series 10119, The World Bank.
    5. Nadine Riedel & Martin Simmler, 2018. "Large and Influential: Firm Size and Governments' Corporate Tax Rate Choice," CESifo Working Paper Series 6904, CESifo.
    6. Behnam Karamshahi & Zeinab Azami & Tabandeh Salehi, 2018. "The association between competition power in markets and tax avoidance: evidence from Tehran stock exchange," Eurasian Business Review, Springer;Eurasia Business and Economics Society, vol. 8(3), pages 323-339, September.
    7. Dubois, Pierre & Magnac, Thierry, 2024. "Optimal intertemporal curative drug expenses: The case of hepatitis C in France," Journal of Health Economics, Elsevier, vol. 94(C).
    8. Mauro Caselli & Arpita Chatterjee & Shengyu Li, 2023. "Productivity and Quality of Multi-product Firms," Discussion Papers 2023-10, School of Economics, The University of New South Wales.
    9. Younes, George Abi & Ayoubi, Charles & Ballester, Omar & Cristelli, Gabriele & de Rassenfosse, Gaetan & Foray, Dominique & Gaule, Patrick & Pellegrino, Gabriele & van den Heuvel, Matthias & Webster, B, 2020. "COVID-19_Insights from Innovation Economists," SocArXiv b5zae, Center for Open Science.
      • Dominique Foray & Gaetan de Rassenfosse & George Abi Younes & Charles Ayoubi & Omar Ballester & Gabriele Cristelli & Matthias van den Heuvel & Ling Zhou & Gabriele Pellegrino & Patrick Gaulé & Elizab, 2020. "COVID-19: Insights from Innovation Economists," Working Papers 10, Chair of Science, Technology, and Innovation Policy.
    10. Paul H. Rubin & Mark A. Cohen, 1992. "Politically Imposed Entry Barriers," Eastern Economic Journal, Eastern Economic Association, vol. 18(3), pages 333-344, Summer.
    11. Brian Kelleher Richter & Krislert Samphantharak & Jeffrey F. Timmons, 2009. "Lobbying and Taxes," American Journal of Political Science, John Wiley & Sons, vol. 53(4), pages 893-909, October.
    12. Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2022. "The price of cost-effectiveness thresholds," NIPE Working Papers 5/2022, NIPE - Universidade do Minho.
    13. Ted Hayduk, 2022. "Association membership, election cycles, and political donation patterns," Economics of Governance, Springer, vol. 23(3), pages 359-384, December.
    14. Fabian Gaessler & Stefan Wagner, 2022. "Patents, Data Exclusivity, and the Development of New Drugs," The Review of Economics and Statistics, MIT Press, vol. 104(3), pages 571-586, May.
    15. James Alt, 1983. "The evolution of tax structures," Public Choice, Springer, vol. 41(1), pages 181-222, January.
    16. Sverker Sikström & Laura Mai Stoinski & Kristina Karlsson & Lotta Stille & Johan Willander, 2020. "Weighting power by preference eliminates gender differences," PLOS ONE, Public Library of Science, vol. 15(11), pages 1-19, November.
    17. Richard Damania & Per G. Fredriksson & Thomas Osang, 2005. "Polluters and Collective Action: Theory and Evidence," Southern Economic Journal, John Wiley & Sons, vol. 72(1), pages 167-185, July.
    18. Jing Zhang & Justin Tan & Poh Wong, 2015. "When does investment in political ties improve firm performance? The contingent effect of innovation activities," Asia Pacific Journal of Management, Springer, vol. 32(2), pages 363-387, June.
    19. Beth Woods & James Lomas & Mark Sculpher & Helen Weatherly & Karl Claxton, 2024. "Achieving dynamic efficiency in pharmaceutical innovation: Identifying the optimal share of value and payments required," Health Economics, John Wiley & Sons, Ltd., vol. 33(4), pages 804-819, April.
    20. Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2024. "Competing with precision: incentives for developing predictive biomarker tests," Scandinavian Journal of Economics, Wiley Blackwell, vol. 126(1), pages 60-97, January.
    21. repec:zbw:bofitp:2013_006 is not listed on IDEAS
    22. Tomaso Duso & Astrid Jung, 2003. "Market Conduct and Endogenous Lobbying: Evidence from the U.S. Mobile Telecommunications Industry," Vienna Economics Papers vie0315, University of Vienna, Department of Economics.
    23. Gianfranco Marotta & Phillipe Krahnhof & Cam-Duc Au, 2022. "A Critical Analysis of Budgeting Processes from the Pharmaceutical Industry and Beyond," Journal of Applied Finance & Banking, SCIENPRESS Ltd, vol. 12(3), pages 1-3.

    More about this item

    NEP fields

    This paper has been announced in the following NEP Reports:

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:osf:socarx:z5mf6. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: OSF (email available below). General contact details of provider: https://arabixiv.org .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.